About
Technology
Issues
FAQ
Links
Official Page
First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.